The dilemma for patients with chronic hepatitis C: treat now or warehouse?

Dig Liver Dis. 2014 Jan;46(1):27-9. doi: 10.1016/j.dld.2013.10.006. Epub 2013 Nov 21.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Carriers / therapeutic use
  • Drug Discovery*
  • Drug Therapy, Combination
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Oligopeptides / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Proline / analogs & derivatives
  • Proline / therapeutic use
  • Protease Inhibitors / therapeutic use*
  • Ribavirin / therapeutic use*
  • Time Factors
  • Watchful Waiting*

Substances

  • Antiviral Agents
  • Drug Carriers
  • Interferon-alpha
  • Oligopeptides
  • Protease Inhibitors
  • Polyethylene Glycols
  • Ribavirin
  • telaprevir
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline